Ring Therapeutics locks in $117m Series B

Ring Therapeutics, a life sciences company, has raised $117 million in Series B funding.

Ring Therapeutics, a life sciences company, has raised $117 million in Series B funding. The backers included Invus, Altitude Life Science Ventures, Partners Investment, UPMC Enterprises, T. Rowe Price Associates, Inc and Flagship Pioneering.

Source: Press Release